Actively Recruiting
Comparison of Short and Long-term Outcomes in Gastric Cancer Patients Undergoing Reduced Port Versus Traditional Laparoscopic Gastrectomy
Led by Nanchong Central Hospital · Updated on 2025-05-21
160
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and outcomes of reduced port laparoscopic gastrectomy compared to traditional laparoscopic gastrectomy in patients with gastric cancer. This study aims to systematically compare both short-term and long-term results following these surgical approaches. The short-term outcomes include surgical complications, postoperative morbidity, and nutritional status, while the long-term outcomes focus on survival rates. The study involves two groups: one undergoing reduced port laparoscopic gastrectomy, which uses 1 to 3 ports during surgery, and another receiving the standard laparoscopic gastrectomy with 5 ports. These groups are compared to assess differences in surgical and recovery outcomes. The study is non-randomized and single-blinded, with patients assigned to either surgical method. Participants will be monitored for surgical complications, nutrition, and quality of life using the PGSAS-45 scale over several months following surgery. Survival rates at 3 and 5 years will be tracked as primary outcomes. The study includes regular assessments during the first year and follows participants for up to five years to evaluate long-term survival and recovery.
CONDITIONS
Brief Title
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed adenocarcinoma of the stomach, stages T1 to T4
- Eastern Cooperative Oncology Group performance status of 0 or 1
- Adequate organ function
- Age between 18 and 90 years
You will not qualify if you...
- Presence of distant metastasis
- Oesophageal invasion longer than 3 cm
- Borrmann type 4 or large (more than 8 cm) type 3 carcinoma
- Previous chemotherapy or radiation therapy for any other malignancies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay duration (varies per participant)
Participants undergo either reduced port laparoscopic gastrectomy or standard laparoscopic gastrectomy for gastric cancer and receive immediate post-operative care.
1 surgery visit and several in-hospital post-operative assessments
Duration - Up to 12 months
Participants are monitored for post-operative morbidity, nutritional status, and quality of life following surgery.
Multiple follow-up visits over 12 months
Duration - Up to 5 years
Participants are followed to assess long-term survival outcomes up to 5 years after surgery.
Periodic visits for survival assessments
Trial Site Locations
Total: 1 location
1
Yunhong Tian
Nanchong, Sichuan, China, 637000
Actively Recruiting
Research Team
Y
Yunhong Tian, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here